Menu Back toLeveraging Pharma Intelligence Data and Statistical Modeling to Inform Project Strategies
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
Leveraging Pharma Intelligence Data and Statistical Modeling to Inform Project Strategies
Mark Kryah, PMP
- Executive Director/Program Team Leader
- Ultragenyx Pharmaceutical, United States
This session will explore use of external intelligence data sources in advanced statistical modeling to inform program strategies and clinical designs. Case studies will be shared.
Learning Objective : Describe various external data sources that can be used for statistical modeling; Identify how to use statistical modeling approaches leveraging this external data; Discuss how statistical modeling can inform and influence project strategies and clinical designs.
Informing Drug Development via Landscape Modeling Using Pharma Intelligence Data
Zhaoling Meng, PhD, MS
- AVP, Global Head of Clinical Modeling and Evidence Integration
- Sanofi, United States
Application of Advanced Modeling on Development Programs
Shameer Khader, PhD, MPH
- Senior Director, Data Science and Artificial Intelligence
- AstraZeneca, United States